ramatroban has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altavilla, D; Campo, GM; Canale, P; Caputi, AP; Faggiotto, A; Ioculano, M; Oriti, S; Saitta, A; Squadrito, F; Zingarelli, B | 1 |
| Fiedler, VB; Perzborn, E; Seuter, F | 1 |
2 other study(ies) available for ramatroban and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
Topics: Animals; Carbazoles; Creatine Kinase; Hemodynamics; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1993 |
Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
Topics: Animals; Carbazoles; Coronary Circulation; Dogs; Female; Hemodynamics; Humans; Infusions, Intravenous; Ligation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Sulfonamides; Thromboxanes; Time Factors; Ventricular Fibrillation | 1991 |